Abstract
Two peptides that can selectively bind to SEVI and block the enhanced infectivity that results from the interaction of SEVI with HIV. The two peptides comprise the amino acid sequences FEEIVQEIEDFLENLV (SEQ. ID NO: 1) and GIGAVLEVLTTGLPALISWIEEEEQQ (SEQ. ID. NO: 2). The peptides may be administered topically, either alone or in combination with other prophylactics, agents, etc.
| Original language | English (US) |
|---|---|
| Patent number | 10,695,399 |
| Priority date | 8/1/17 |
| Filing date | 11/1/19 |
| State | Accepted/In press - Feb 20 2020 |